Psyence Group Stock Price, News & Analysis
Company Description
Psyence Group (OTC Link: PSYGF) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $1.8M.
PSYGF stock has declined 42.0% over the past year. Shares last traded at $0.1270.
This page provides a comprehensive overview of PSYGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Psyence Group (PSYGF) stock last traded at $0.1270. Over the past 12 months, the stock has lost 42.0%. At a market capitalization of $1.8M, PSYGF is classified as a micro-cap stock with approximately 15.6M shares outstanding.
Latest News
Psyence Group has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all PSYGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Psyence Group (PSYGF) currently stands at 1 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 99%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Psyence Group (PSYGF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
PSYGF Company Profile & Sector Positioning
Psyence Group (PSYGF) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PSYGF often look at related companies in the same sector, including Thc Biomed Intl (THCBF), Medical Mari (MJNA), STEMTECH CORPORATION (STEK), Anything Technologies Media (EXMT), and Cannapharmarx (CPMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PSYGF's relative position within its industry.